Trouble with Causality: Contribution of Hallucinogens, Antidepressives and Isotretinoin to Development of Depression and the Suicidal Behaviour

1. American Psychiatric Association: DSM IV, APA, 1994, Washington D.C.

2. Smolík, P.: Duševní a behaviorální poruchy. Praha, Maxdorf, 2002.

3. Nace, E.: Substance abuse and personality disorder, managing the dually diagnosed patient, Current issues and clinical approaches. David F., O’Connell, editor. Binghamton, New York, The Haworth Press, Inc., 1990.

4. Milkman, H., Sunderwirth, S.: Craving for ecstasy, the consciousness & chemistry of escape. Lexington, Massachusetts: Lexington Books, 1997.

5. Walant, K.: Creating the capacity for attachment treating addictions and the alienated self. Northvale, New Jersey: Jason Aronson Inc., 1995.

6. www.Roche.cz

7. Lowenstein, E. J.: Isotrenoin made S.M.A.R.T. and simple. Cutis, 70, 2002,. 2, pp. 115-120.

8. O´Donnnell, J.:. Polar hysteria: an expression of hyperviatminosis A. Am. J. Ther., 11, 2004, 6, pp. 507-516.

9. http://www.fda.gov/cder/drug/infopage/accutane/default.htm

10. Hazen, P. G. et al.: Depression – a side effect of 13-cis-retinoic acid therapy. J. Am. Acad. Dermatol., 1983, pp. 278-279.

11. Wysowski, D. et al.: An analysis of reports of depression and suicide in patients treated with isotretinoin. New Engl. J. Med., 344, 2001, 6, pp. 460-461.

12. Magin, P. et al.: Isotretinoin, depression and suicide: a review of the evidence. Br. J. Gen. Pract., 511, 2005, 55, pp. 134-138.

13. Strahan, J. E. et al.: Isotretinoin and the controversy of psychiatric adverse effects. Int. J. Dermatol., 45, 2006, pp. 789-799.

14. Kellet, S. C. et al.: The psychological and emotional impact of acne and the effect of tretment with isotretinoin. Br. J. Dermatol., 140, 1999, 2, pp. 273-282.

15. Antonio, J., Tallé, S.:. Acute depression caused by isotretinoin: does it exist? J. Eur. Acad. of Dermatol. and Venereol., 21, 2007, 4, pp. 556–557.

16. Substance-Induced Mood Disorder With Depressive Features http://www.emedicine.com/med/topic533.htm

17. Teicher, M. H. et al.: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am. J Psychiatry, 147, 1990, pp. 207-210.

18. FDA Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications http://www.fda. gov/cder/drug/advisory/SSRI200507.htm

19. Fergusson, D., Doucette, S., Glass, K. C. et al.: Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ, 330, 2005, 19, (7488) p. 396.

20. Juurlink, et al.: The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am. J. Psychiatry, 163, 2006, pp. 813-821.

21. Simon, G. E.: How can we know whether antidepressants increase suicide risk? Am, J. Psychiatry, 163, 2006, pp. 1861-1863.

22. First, M. B.: Diagnostic issues in substance use disorders http://dsm5.org/conference4.cfm.